UK Coagulation Testing Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies

NEW YORK, Aug. 20, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

UK Coagulation Testing Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies

http://www.reportlinker.com/p01598563/UK-Coagulation-Testing-Market-2013---Sales-Forecasts-Supplier-Shares-Competitive-Strategies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market during the next five years.

The report explores business and technological trends in the UK coagulation testing market; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

Coagulation Tests

Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.

Sales and Market Share Analysis

- Sales and market shares of major instrument and reagent suppliers.

Competitive Assessments

- Extensive strategic profiles of major suppliers and emerging market entrants.

Market Segmentation Analysis

- Comprehensive marketsegmentation analysis, including:

- Hospitals

- Commercial/Private Laboratories

- Test volume forecasts for over 40 major procedures by market segment.

Current and Emerging Products

- Review of established and emerging procedures.

- Comparison of automated and semi-automated

analyzers from Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers.

Technology Review

- Comprehensive lists of companies developing or marketing new technologies and products by test.

Strategic Recommendations

- Product development and business expansion opportunities with significant market appeal.

- "Ideal" product models with tentative

prices and operating characteristics.

- Alternative market penetration strategies for instrument and reagent suppliers.

- Potential market entry barriers and risks.

I. Introduction

II. Worldwide Market and Technology Overview

A. Major Routine and Special Coagulation Tests1. Introduction2. Activated Partial Thromboplastin Time (APTT)3. Alpha-2 Antiplasmin4. Antithrombin III5. Bleeding Time6. D-Dimer7. Ethanol Flocculation Test8. Euglobulin Lysis9. Factor Assaysa. Introductionb. Factor IIc. Factor V/Factor V Leidend. Factor VIIe. Factor VIIIf. Factor IXg. Factor IXah. Factor X (Stuart Factor)i. Factor Xaj. Factor XIk. Factor XIIl. Factor XIII10. Fibrin Degradation Products11. Fibrinogen12. Heparin13. Hirudin14. Hypercoagulability and Thrombosis15. Lipoprotein a16. Plasmin17. Plasminogen18. Plasminogen Activator Inhibitor (PAI)19. Platelet Function Tests20. Platelet Aggregation21. Proteins C and S22. Prothrombin Fragment 1.223. Prothrombin Time (PT) 24. Reptilase Time25. Thrombin Time26. Tissue-Type Plasminogen Activator (t-PA)27. Von Willebrand's FactorB. Instrumentation ReviewC. Major in Vitro Diagnostic Technologies and TheirPotential Applications1. Chromogenic Substrates2. Monoclonal and Polyclonal Antibodies3. Immunoassays4. Molecular Diagnostics5. Microcomputers6. Automation7. Robotics8. Artificial Intelligence9. Dry Chemistry10. Biosensors

III. U.K.

A. Executive SummaryB. Business EnvironmentC. Market StructureD. Market Size, Growth and Major Instrument and Reagent Suppliers' Sales and Market Shares

X. Major Product Development Opportunities

XI. Design Criteria For Decentralized Testing Products

XII. Alternative Market Penetration Strategies

A. Internal DevelopmentB. Collaborative ArrangementsC. University ContractsD. Distribution Strategies for Decentralized Testing Markets1. Marketing Approaches2. Product Complexity3. Customer Preference4. Established Suppliers5. Emerging Suppliers6. Major Types Of Distributors7. Market Segmentation

XIII. Potential Market Entry Barriers and Risks

A. Market MaturityB. Cost ContainmentC. CompetitionD. Technological Edge and LimitationsE. Patent ProtectionF. Regulatory ConstraintsG. Decentralized Testing Market Challenges

XIV. Competitive Assessments

- Abbott- ADI/American Diagnostic- Axis-Shield- Alere/Biosite/Inverness- Beckman Coulter/Danaher- Becton Dickinson- Bio/Data Corporation- Chrono-Log- Corgenix Medical- Diagnostica Stago/Trinity Biotech- Helena Laboratories- HYPEN BioMed- Instrumentation Laboratory- ITC- Roche- Siemens- Sienco- Sysmex- Thermo Fischer- ZyCare/Alere

List of Tables

Major Companies Developing or Marketing Activated Clotting Time TestsMajor Companies Developing or Marketing APTT TestsMajor Companies Developing or Marketing Alpha-2 Antiplasmin TestsMajor Companies Developing or Marketing Antithrombin III TestsMajor Companies Developing or Marketing Bleeding Time TestsMajor Companies Developing or Marketing D-dimer TestsMajor Companies Developing or Marketing Factor AssaysMajor Companies Developing or Marketing Fibrin Degradation Product TestsMajor Companies Developing or Marketing Fibrinogen TestsMajor Companies Developing or Marketing Heparin TestsMajor Companies Developing or Marketing Plasmin TestsMajor Companies Developing or Marketing Plasminogen TestsMajor Companies Developing or Marketing Plasminogen ActivatorInhibitor TestsMajor Companies Developing or Marketing Platelet Aggregation TestsMajor Companies Developing or Marketing Protein C TestsMajor Companies Developing or Marketing Protein S TestsMajor Companies Developing or Marketing PT TestsMajor Companies Developing or Marketing Thrombin Time TestsMajor Companies Developing or Marketing TPA TestsMajor Companies Developing or Marketing Von Willebrand'sFactor Tests Executive Summary Table: U.K., Total Coagulation DiagnosticsMarket By Market Segment and Product CategoryU.K., Laboratories Performing Coagulation Tests By Market Segment U.K., Hospital Laboratories Performing Coagulation Tests By Bed SizeU.K., Commercial/Private Laboratories Performing Coagulation Tests By Annual Test VolumeU.K., Hospital Laboratories Average Daily Test Volume U.K., Commercial/Private Laboratories Average Daily Test VolumeU.K., Total Coagulation Test Volume By Market SegmentU.K., All Market Segments Coagulation Test VolumeU.K., Hospital Laboratories Coagulation Test VolumeU.K., Commercial/Private Laboratories Coagulation Test VolumeU.K., Coagulation Reagent Market By Market SegmentU.K., Major Suppliers of Coagulation Reagents Estimated Sales and Market Shares U.K., Coagulation Instrument Market By Market SegmentU.K., Major Suppliers of Coagulation Analyzers, Estimated Instrument Sales and Market SharesU.K., Total Coagulation Diagnostics Market By Product Category U.K., Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares

To order this report:In_Vitro_Diagnostic Industry: UK Coagulation Testing Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies

Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001

SOURCE Reportlinker